Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

239 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

A Study of GLB-001 in Patients With Myeloid Malignancies

NCT06378437

Conditions
Acute Myeloid Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +21 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • The First Hospital of Hebei Medical Universtiy Shijiazhuang, Hebei, China
View all 14 locations
View Trial Details
Recruiting

A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera

NCT06752746

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital Zhengzhou, Henan, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

NCT05423691

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +9 more
Locations
  • UC Davis Health Sacramento, California, United States
  • Columbia University New York, United States
  • Montefiore Einstein Cancer Center The Bronx, New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions